Parker Geoffrey M.
Chief Financial Officer
Sale
Calculated transaction value
$48.7K
36,342 shares @ $1.34
Traded
Oct 21, 2026
Filed
Oct 23, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Allogene Therapeutics
ALLO
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
13 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Parker Geoffrey M. Chief Financial Officer | Oct 23, 2026 2-day lag | Sale Oct 21, 2026 | $48.7K Filed shares x price | SEC Form 4 View filing | |
| Douglas Earl Martin SVP, General Counsel | Aug 25, 2026 4-day lag | Sale Aug 21, 2026 | $62.96K Filed shares x price | SEC Form 4 View filing | |
| Roberts Zachary President And CEO | Jul 6, 2026 5-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Roberts Zachary President And CEO | Jul 6, 2026 5-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kazam Joshua A Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Messemer Deborah M. Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Mayo Stephen Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kazam Joshua A Director | Jun 23, 2026 5-day lag | Exercise Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Witte Owen N. Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Humer Franz B Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Barrett Elizabeth A. Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sato Vicki L Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kazam Joshua A Director | Jun 23, 2026 5-day lag | Award Jun 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Douglas Earl Martin
SVP, General Counsel
Sale
Calculated transaction value
$62.96K
29,697 shares @ $2.12
Traded
Aug 21, 2026
Filed
Aug 25, 2026
Roberts Zachary
President And CEO
Award
Calculated transaction value
$0
476,190 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 6, 2026
Roberts Zachary
President And CEO
Award
Calculated transaction value
$0
134,530 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 6, 2026
Kazam Joshua A
Director
Exercise
Calculated transaction value
$0
47,700 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Messemer Deborah M.
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Mayo Stephen
Director
Award
Calculated transaction value
$0
144,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Kazam Joshua A
Director
Exercise
Calculated transaction value
$0
47,700 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Witte Owen N.
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Humer Franz B
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Barrett Elizabeth A.
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Sato Vicki L
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026
Kazam Joshua A
Director
Award
Calculated transaction value
$0
95,400 shares @ $0
Traded
Jun 18, 2026
Filed
Jun 23, 2026